Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Blood|November 11, 2017
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapyAnja Mottok, Vindi Jurinovic, Pedro Farinha, et al.
British Journal of Haematology|August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma NetworkHilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study GroupWolfram Klapper, Eva Hoster, Lars Rölver, et al.
Blood Advances|April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphomaDiego Villa, Eva Hoster, Olivier Hermine, et al.
Virchows Archiv : an International Journal of Pathology|January 25, 2020
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11Giorgio A Croci, Eva Hoster, Sílvia Beà, et al.
Cancers|July 27, 2022
Treatment of RET-Positive Advanced Medullary Thyroid Cancer with Multi-Tyrosine Kinase Inhibitors-A Retrospective Multi-Center Registry AnalysisViktoria Florentine Koehler, Pia Adam, Carmina Teresa Fuss, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2023
Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly TrialEva Hoster, Marie-Hélène Delfau-Larue, Elizabeth Macintyre, et al.
International Journal of Cancer|July 9, 2020
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trialTobias Roider, Xi Wang, Katrin Hüttl, et al.
Thyroid : Official Journal of the American Thyroid Association|August 18, 2021
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid CancerViktoria Florentine Koehler, Elke Berg, Pia Adam, et al.
Pageof 11